Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia

PHASE3CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 10, 2018

Study Completion Date

January 10, 2018

Conditions
Staph Aureus Methicillin Resistant Bacteremia
Interventions
DRUG

Fosfomycin 2gr/6h iv

DRUG

Daptomycin 10mg/kg/24h iv

Trial Locations (18)

18014

Hospital Universitario Virgen de las Nieves, Granada

25198

Hospital Universitari Arnau de Vilanova, Lleida

27004

Hospital Universitario Lucus Augusti, Lugo

28007

Hospital General Gregorio Marañon, Madrid

28034

Hospital Ramon y Cajal, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

41071

Hospital Virgen Macarena, Seville

43007

Hospital Universitari Joan XXIII, Tarragona

48903

Hospital Universitario de Cruces, Barakaldo

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

08208

Hospital Parc Taulí, Sabadell

08221

Hospital Universitari Mútua de Terrassa, Terrassa

08227

Hospital de Terrassa, Terrassa

08003

Hospital del Mar- Parc de Salut Mar, Barcelona

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

08035

Hospital Vall d'Hebron, Barcelona

08036

Hospital Clinic, Barcelona

07120

Complejo Asistencial Son Espases, Palma de Mallorca

All Listed Sponsors
collaborator

Hospital Universitari de Bellvitge

OTHER

lead

Miquel Pujol

OTHER

NCT01898338 - Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia | Biotech Hunter | Biotech Hunter